Company
Tres Cantos Open LAB Foundation
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Tres Cantos Open LAB Foundation. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 9
- Audra Jane Halsey 2020-2024 View profile
- Professor Baron Peter Piot Kcmg 2017-2020 View profile
- Jose-Maria Romero Rodriguez 2015-2020 View profile
- Professor Alan Hutchinson Fairlamb 2014-2026 View profile
- Professor Sir Leszek Krzysztof Borysiewicz 2011-2016 View profile
- Professor Dr Pedro Luis Alonso Fernandez 2011-2014 View profile
- Glaxo Group Limited 2010-2011 View profile
- Edinburgh Pharmaceutical Industries Limited 2010-2011 View profile
- Alison Jane Strutt 2010-2015 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- Incorporated
- 01/07/2010
- Also a registered charity
- Tres Cantos Open LAB Foundation
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Glaxo Group Limited
75-100% voting, appoints directors · notified 2016-04-06
Group
- Tres Cantos Open LAB Foundation
is controlled by Glaxo Group Limited
Evidence
active 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register - Glaxo Group Limited
is controlled by Glaxosmithkline Finance PLC
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register - Glaxosmithkline Finance PLC
is controlled by Glaxosmithkline Holdings Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register - Glaxosmithkline Holdings Limited
is controlled by GSK PLC
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by GSK PLC.
86 other companies in this group
- Smithkline Beecham Legacy H Limited
- Smithkline Beecham Overseas Limited
- GSK LP Limited
- Setfirst Holdings Limited
- Stevenage Bioscience Catalyst
- Glaxo Laboratories Limited
- Smithkline Beecham Senior Executive Pension Plan Trustee Limited
- Glaxosmithkline IHC Limited
- Smithkline Beecham Marketing and Technical Services Limited
- Stiefel Laboratories (Maidenhead) Limited
- Action Potential Venture Capital Limited
- Viiv Healthcare Finance Limited
- Charles Midgley Limited
- GSK Finance (NO 2) Limited
- Glaxosmithkline Caribbean Limited
- Burroughs Wellcome International Limited
- Smithkline Beecham Pension Trustees Limited
- Stiefel Laboratories Limited
- Glaxosmithkline Mercury Limited
- Setfirst Limited
- Dealcyber Limited
- GSK Finance (NO.3) Limited
- Viiv Healthcare UK (NO.5) Limited
- Viiv Healthcare Finance 2 Limited
- Wellcome Consumer Healthcare Limited
- Glaxo Wellcome UK Limited
- Glaxosmithkline Intellectual Property Management Limited
- Glaxosmithkline Intellectual Property Limited
- Mixis Genetics Limited
- Glaxo Group Limited
- Allen & Hanburys Limited
- Glaxosmithkline Intellectual Property Holdings Limited
- Smithkline Beecham (Export) Limited
- Glaxosmithkline Intellectual Property Development Limited
- Viiv Healthcare Trading Services UK Limited
- Viiv Healthcare Finance 1 Limited
- Clarges Pharmaceuticals Limited
- Glaxo Trustees Limited
- Glaxosmithkline International Limited
- Glaxochem (UK) Unlimited
- Viiv Healthcare Limited
- Viiv Healthcare UK (NO.3) Limited
- Glaxosmithkline Intellectual Property (NO.5) Limited
- Eskaylab Limited
- Glaxosmithkline Intellectual Property (NO.2) Limited
- Viiv Healthcare UK (NO.4) Limited
- Cellzome Limited
- Smithkline Beecham (SWG) Limited
- Smith Kline & French Laboratories Limited
- Glaxosmithkline Export Limited
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
4 directors on the board
- Valerie Mizrahi Director · appointed 2024
- Steven Sheldon Director · appointed 2024
- Kenneth Duncan Director · appointed 2022
- Professor Carl Francis Nathan Director · appointed 2016
Directors past 6 years
- Professor Carl Francis Nathan Director · appointed 2016
First-time vs portfolio directors
First-time (4)
- Valerie Mizrahi Director · appointed 2024
- Steven Sheldon Director · appointed 2024
- Kenneth Duncan Director · appointed 2022
- Professor Carl Francis Nathan Director · appointed 2016
Left in the last 12 months
- Professor Alan Hutchinson Fairlamb Director · appointed 2014 · resigned 2026
Gaps to watch
- No director brings board experience from anywhere else
- Narrow spread of sectors across the board
Where to look Suggested search: a director with board experience elsewhere; directors from a wider range of sectors.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 07301222
- Status
- Active
- Type
- PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data